Loss of collapsin response mediator protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII

Cancer Research

Volumn 69, Issue 22, 2009, Pages 8545-8554

  Mukherjee, Joydeep ^a   DeSouza, Leroi V ^b   Micallef, Johann ^a   Karim, Zia ^a   Croul, Sid ^c   Siu, K W Michael ^b   Guha, Abhijit ^a,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b YORK UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 8; MUTANT PROTEIN; RAC PROTEIN; RHO FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL INVASION; CELL PROLIFERATION; CHEMICAL LABELING; CONTROLLED STUDY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; WILD TYPE;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MUTATION; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; RAC GTP-BINDING PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHOA GTP-BINDING PROTEIN;

EID: 72249111499     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1778     Document Type: Article

References (48)

1. Ekstrand AJ, James CD, Cav enee WK, Seliger B, Pettersson RF, Collins VP. Genes for epidermal growth factor receptor, transforming growth factor á, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 1991;51:2164-2172
2. Schlegel J, Merdes A, Stumm G, et al. Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer 1994;56:72-77 (Pubitemid 24044796)
3. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A 1987;84:6899-6903
4. Ekstrand AJ, Sugawa N, James CD, Collins VP. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci U S A 1992;89:4309-4313
5. Malden LT, Novak U, Kaye AH, Burgess AW. Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res 1988;48:2711-2714 (Pubitemid 18137737)
6. Sugawa N, Ekstrand AJ, James CD, Collins VP. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci U S A 1990; 87:8602-8606 (Pubitemid 20373140)
7. Wong AJ, Ruppert JM, Bigner SH, et al. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci U S A 1992;89: 2965-2969
8. Libermann TA, Nusbaum HR, Razon N, et al. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 1985;313:144-147 (Pubitemid 15192341)
9. Nishikawa R, Ji XD, Harmon RC, et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A 1994;91:7727-7731 (Pubitemid 24238258)
10. Hurtt MR, Moossy J, Donovan-Peluso M, Locker J. Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol 1992;51:84-90.
11. Cho WC, Cheng CH. Oncoproteomics: current trends and future perspectives. Expert Rev Proteomics 2007;4: 401-410 (Pubitemid 46890077)
12. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003;21:1624-1636 (Pubitemid 46594118)
13. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME. Molecular targets of glioma invasion. Cell Mol Life Sci 2007;64:458-478
14. Chu CT, Everiss KD, Wikstrand CJ, Batra SK, Kung HJ, Bigner DD. Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII). Biochem J 1997;324:855-861 (Pubitemid 27285544)
15. Huang HS, Nagane M, Klingbeil CK, et al. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem 1997;272:2927-2935 (Pubitemid 27053343)
16. Dong JT, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (New York, NY) 1995;268:884-886
17. Lee JH, Miele ME, Hicks DJ, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996;88:1731-1737
18. Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988;80:200-204 (Pubitemid 18100566)
19. DeSouza L, Diehl G, Rodrigues MJ, et al. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res 2005;4:377-386 (Pubitemid 40548142)
20. DeSouza L, Diehl G, Yang EC, et al. Proteomic analysis of the proliferative and secretory phases of the human endometrium: protein identification and differential protein expression. Proteomics 2005;5:270-281 (Pubitemid 40189657)
21. DeSouza LV, Grigull J, Ghanny S, et al. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 2007;6:1170-1182 (Pubitemid 47099227)
22. Banerjee AK, Read CA, Griffiths MH, George PJ, Rabbitts PH. Clonal divergence in lung cancer development is associated with allelic loss on chromosome 4. Genes Chromosomes Cancer 2007;46:852-860
23. Shih JY, Yang SC, Hong TM, et al. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J Natl Cancer Inst 2001;93:1392-1400 (Pubitemid 32936816)
24. Wu CC, Lin JC, Yang SC, et al. Modulation of the expression of the invasion-suppressor CRMP-1 by cyclooxygenase- 2 inhibition via reciprocal regulation of Sp1 and C/EBPα. Mol Cancer Ther 2008;7:1365-1375
25. Gao M, Yeh PY, Lu YS, Chang WC, Kuo ML, Cheng AL. NF-κB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells. Biochem Biophys Res Commun 2008;376:283-287
26. Rual JF, Hirozane-Kishikawa T, Hao T, et al. Human ORFeome version 1.1: a platform for reverse proteomics. Genome Res 2004;14:2128-2135
27. Rual JF, Venkatesan K, Hao T, et al. Towards a proteome- scale map of the human protein-protein interaction network. Nature 2005;437:1173-1178
28. Benard V, Bohl BP, Bokoch GM. Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J Biol Chem 1999;274:13198-13204 (Pubitemid 129518524)
29. Fiordalisi JJ, Keller PJ, Cox AD. PRL tyrosine phosphatases regulate ρ family GTPases to promote invasion and motility. Cancer Res 2006;66:3153-3161
30. Mateus AR, Seruca R, Machado JC, et al. EGFR regulates ρA-GTP dependent cell motility in E-cadherin mutant cells. Hum Mol Genet 2007;16:1639-1647 (Pubitemid 47050677)
31. Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 1995;376:509-514
32. Fukada M, Watakabe I, Yuasa-Kawada J, et al. Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family. J Biol Chem 2000;275:37957-37965 (Pubitemid 32004917)
33. Gaetano C, Matsuo T, Thiele CJ. Identification and characterization of a retinoic acid-regulated human homologue of the unc-33-like phosphoprotein gene (hUlip) from neuroblastoma cells. J Biol Chem 1997; 272:12195-12201 (Pubitemid 27202804)
34. Quinn CC, Gray GE, Hockfield S. A family of proteins implicated in axon guidance and outgrowth. J Neurobiol 1999;41:158-164 (Pubitemid 29467615)
35. Wang LH, Strittmatter SM. Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase. J Neurochem 1997;69:2261-2269
36. Matsuo T, Stauffer JK, Walker RL, Meltzer P, Thiele CJ. Structure and promoter analysis of the human unc- 33-like phosphoprotein gene. E-box required for maximal expression in neuroblastoma and myoblasts. J Biol Chem 2000;275:16560-16568 (Pubitemid 30398880)
37. Gu Y, Hamajima N, Ihara Y. Neurofibrillary tangleassociated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522. Biochemistry 2000;39:4267-4275
38. Honnorat J, Byk T, Kusters I, et al. Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes. Eur J Neurosci 1999;11: 4226-4232 (Pubitemid 30009253)
39. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001;49:146-154 (Pubitemid 32157990)
40. Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev 2005;6:789-800.
41. Shih JY, Lee YC, Yang SC, Hong TM, Huang CY, Yang PC. Collapsin response mediator protein-1: a novel invasion-suppressor gene. Clin Exp Metastasis 2003;20:69-76.
42. Arimura N, Inagaki N, Chihara K, et al. Phosphorylation of collapsin response mediator protein-2 by ρ- kinase. Evidence for two separate signaling pathways for growth cone collapse. J Biol Chem 2000;275:23973-23980 (Pubitemid 30624686)
43. Hall C, Brown M, Jacobs T, et al. Collapsin response mediator protein switches ρA and Rac1 morphology in N1E-115 neuroblastoma cells and is regulated by ρ kinase. J Biol Chem 2001;276:43482-43486 (Pubitemid 37371040)
44. Hall A. ρ GTPases and the control of cell behaviour. Biochem Soc Trans 2005;33:891-895
45. Raftopoulou M, Hall A. Cell migration: ρ GTPases lead the way. DevBiol 2004;265:23-32.
46. Moorman JP, Luu D, Wickham J, Bobak DA, Hahn CS. A balance of signaling by ρ family small GTPases ρA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival. Oncogene 1999;18:47-57.
47. Rottner K, Hall A, Small JV. Interplay between Rac and ρ in the control of substrate contact dynamics. Curr Biol 1999;9:640-648 (Pubitemid 29291944)
48. Salhia B, Rutten F, Nakada M, et al. Inhibition of ρ- kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1. Cancer Res 2005; 65:8792-8800 (Pubitemid 41377367)